New AbbVie hepatitis C regimen shows high cure rates: studies

(Reuters) - An experimental once-daily combination hepatitis C treatment being developed by AbbVie Inc demonstrated very high cure rates across a wide range of disease genotypes, according to data presented on Saturday, likely giving the company a more competitive product if approved.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro